The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum

Phytotherapy Research

Volumn 23, Issue 1, 2009, Pages 28-32

  Fatmawati, Sri ^a,b   Kurashiki, Kenji ^a   Takeno, Sayaka ^a   Kim, Yong Ung ^a   Shimizu, Kuniyoshi ^a   Sato, Masao ^a   Imaizumi, Katsumi ^a   Takahashi, Kaori ^c   Kamiya, Shinji ^c   Kaneko, Shuhei ^d   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b DEPARTMENT OF ELECTRICAL ENGINEERING   (Indonesia)

^c TDK CORPORATION   (Japan)

^d Forestry and Forest Products Research Institute   (Japan)

Author keywords

Aldose reductase; Diabetic complications; Ganoderma lucidum

Indexed keywords

AGARICUS BLAZEI EXTRACT; AGROCYBE CYLINDRACEA EXTRACT; ALDEHYDE REDUCTASE; FLAMMULINA VELUTIPES EXTRACT; GALACTITOL; GANODERMA LUCIDUM EXTRACT; GRIFORA FONDOSA EXTRACT; HERICIUM ERINACEUM EXTRACT; HYPOLOMA SUBLATERITIUM EXTRACT; HYPSIZYGUS MARMOREUS EXTRACT; LENTINUS EDODES EXTRACT; LYOPHYLLUM DECASTES EXTRACT; METHANOL; PANELLUS SEROTINUS EXTRACT; PHOLIOTA NAMEKO EXTRACT; PLEUROTUS ABALONUS EXTRACT; PLEUROTUS COMUCOPIAE EXTRACT; PLEUROTUS ERINGII EXTRACT; PLEUROTUS OSTREATUS EXTRACT; UNCLASSIFIED DRUG;

AGARICUS BLAZEI; AGROCYBE CYLINDRACEA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EDIBLE MUSHROOM; ENZYME INHIBITION; FLAMMULINA VELUTIPES; GALACTOSEMIA; GANODERMA LUCIDUM; GRIFORA FONDOSA; HERICIUM ERINACEUM; HUMAN; HYPOLOMA SUBLATERITIUM; HYPSIZYGUS MARMOREUS; LENS; LENTINUS EDODES; LYOPHYLLUM DECASTES; MALE; MUSHROOM; NONHUMAN; PANELLUS SEROTINUS; PHOLIOTA NAMEKO; PLEUROTUS ABALONUS; PLEUROTUS COMUCOPIAE; PLEUROTUS ERINGII; PLEUROTUS OSTREATUS; RAT;

ALDEHYDE REDUCTASE; ANIMALS; ENZYME INHIBITORS; GALACTITOL; HUMANS; LENS, CRYSTALLINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REISHI;

BASIDIOMYCOTA; GANODERMA LUCIDUM; RATTUS;

EID: 58149498820     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2425     Document Type: Article

References (25)

1. American Institute of Nutrition. 1977. Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 107: 1340-1348.
2. Bhatnagar A, Srivastava SK. 1992. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem Med Met Biol 48: 91-121.
3. Cotter MA, Cameron NA, Robertson S. 1992. Polyol pathway-mediated changes in cardiac muscle contractile properties: studies in streptozotocin-diabetic and galactose-fed rats. Exp Physiol 77: 829-838.
4. Duquesne NS, Greselin E, Dubuc J, Dvornik D. 1985. The effects of a new aldose reductase inhibitor (Tolrestat) in galacto-semic and diabetic rats. Metabolism 34: 885-892.
5. Dvornik D, Hohman TC, Basso MD. 1996. Aminoguanidine does not inhibit aldose reductase activity in galactose-fed rats. J Diabetes Complications 10: 23-30.
6. Eisenberg DM, Davis RB, Ettner SL et al. 1998. Trends in alternative medicine use in the United States 1990-1997: results of a follow-up national survey. JAMA 280: 1569-1575.
7. Eisenberg DM, Kessler RC, Foster C, Norlock F, Calkins DR, Delbanco TL. 1993. Unconventional medicine in the United States - prevalence, costs, and pattern of use. N Engl J Med 328: 246-252.
8. El-Mekkawy S, Meselhy MR, Nakamura N et al. 1998. Anti- HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 49: 1651-1657.
9. 2 activity of extracts from lanostane-rich species. J Ethno-pharmacol 73: 61-69.
10. Griffey RH, Sibbit JRWL, Sibbit RR et al. 1994. Polyol and water accumulation in muscle of galactose-fed rats. Biochem Pharmacol 48: 1839-1841.
11. Hsieh C, Tseng MH, Liu CJ. 2006. Production of polysaccharides from Ganoderma lucidum (CCRC 36041) under limitations of nutrients. Enzyme Microbial Technol 38: 109-117.
12. Jung SH, Lee YS, Shim SH et al. 2005. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. Phytother Res 19: 477-480.
13. Lee S, Shim SH, Kim JS, Shin KH, Kang SS. 2005. Aldose reductase inhibitors from the fruiting bodies of Ganoderma applanatum. Biol Pharm Bull 28: 1103-1105.
14. Liu J, Kurashiki K, Shimizu K, Kondo R. 2006. 5Alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum. Biol Pharm Bull 29: 392-395.
15. Liu J, Yang F, Ye LB et al. 2004. Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Ethnopharmacol 95: 265-272.
16. Manius G, Mahn FP, Ventrulla VS, Senkowski BZ. 1972. GLC determination of sorbitol and mannitol in aqueous solutions. J Pharm Sci 61: 1831-1835.
17. Muller CI, Kumagai T, Kelly JO, Seeram NP, Heber DC, Koeffler HP. 2006. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leukemia Res30: 841-848.
18. Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. 1991. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim Biophys Acta 1078: 171-178.
19. Patterson RRM. 2006. Ganoderma - A therapeutic fungal biofactory. Phytochemistry 67: 1985-2001.
20. Quan-Ma R, Wells WW. 1965. Distribution of galactitol in tissues of rats fed galactose. Biochem Biophys Res Commun 20: 486-490.
21. Settimo FD, Primofiore G, Motta CL et al. 2005. Spirohydantoin derivatives of thiopyrano[2,3-b]pyridine-4(4H)-one as potent in vitro and in vivo aldose reductase inhibitors. Biorganic Med Chem 13: 491-499.
22. Toth JO, Luu B, Ourisson G. 1982. Les acides ganoderiques t aà z : triterpenes cytotoxiques de Ganoderma lucidum (Polyporacée). Tetrahedron Lett 24: 1081-1084.
23. Wang H, Ng TB. 2006. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides 27: 27-30.
24. Yoon SY, Eo SK, Kim YS, Lee CK, Han SS. 1994. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharmacal Res17: 438-442.
25. Zandt MCV, Jones ML, Gunn DE et al. 2005. Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (Lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J Med Chem 48: 3141-3152.